Pdt Partners, LLC Ab Cellera Biologics Inc. Transaction History
Pdt Partners, LLC
- $1.01 Billion
- Q1 2024
A detailed history of Pdt Partners, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 247,478 shares of ABCL stock, worth $732,534. This represents 0.11% of its overall portfolio holdings.
Number of Shares
247,478
Previous 247,378
0.04%
Holding current value
$732,534
Previous $1.41 Million
20.61%
% of portfolio
0.11%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding ABCL
# of Institutions
171Shares Held
120MCall Options Held
264KPut Options Held
254K-
Baker Bros. Advisors LP New York, NY27.5MShares$81.5 Million1.58% of portfolio
-
Baillie Gifford & CO23.2MShares$68.6 Million0.08% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$31.5 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA8.35MShares$24.7 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$13.5 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $844M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...